v3.26.1
Stockholders’ Deficit - Schedule of Stock Options Roll Forward (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Apr. 30, 2026
Jan. 31, 2026
Number of Options    
Outstanding, beginning of period (in shares) 8,970,353  
Granted (in shares) 0  
Exercised (in shares) (152,660)  
Cancelled (in shares) 0  
Outstanding, end of period (in shares) 8,817,693 8,970,353
Options vested, number of options (in shares) 3,649,981  
Options exercisable, number of options (in shares) 3,649,981  
Weighted- Average Exercise Price    
Outstanding, beginning of period (in dollars per share) $ 29.20  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 4.21  
Cancelled (in dollars per share) 0  
Outstanding, end of period (in dollars per share) 29.63 $ 29.20
Options vested, weighted average exercise price per share (in dollars per share) 26.28  
Options exercisable, weighted average exercise price per share (in dollars per share) $ 26.28  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]    
Options outstanding, weighted average remaining contractual term 7 years 4 months 24 days 7 years 7 months 6 days
Options vested, weighted average remaining contractual term 6 years 8 months 12 days  
Options exercisable, weighted average remaining contractual term 6 years 8 months 12 days  
Options outstanding, aggregate intrinsic value $ 207,630 $ 239,954
Options exercised, aggregate intrinsic value 7,200  
Options exercisable, aggregate intrinsic value 98,168  
Options vested, aggregate intrinsic value $ 98,168